Over decades, she underwent extensive ITP-directed therapies, including corticosteroids, intravenous immunoglobulin (IVIG), rituximab, splenectomy, and thrombopoietin receptor agonists (TPO-RAs) like eltrombopag and avatrombopag. The gene discussed is MPL; the disease is autoimmune thrombocytopenic purpura.